Neuralink unveils trial linking brain implant to robotic arm
Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Newsletters and Deep Dive digital magazine
Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Applied Therapeutics plummets after the FDA turns down its marketing application for govorestat as a treatment for galactosaemia
The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD
Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if it was used to treat acute asthma attacks
Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Editor's Picks
Newsletters and Deep Dive
digital magazine